These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
264 related articles for article (PubMed ID: 36142158)
21. NADPH oxidase subunit 4-mediated reactive oxygen species contribute to cycling hypoxia-promoted tumor progression in glioblastoma multiforme. Hsieh CH; Shyu WC; Chiang CY; Kuo JW; Shen WC; Liu RS PLoS One; 2011; 6(9):e23945. PubMed ID: 21935366 [TBL] [Abstract][Full Text] [Related]
22. p53 and miR-210 regulated NeuroD2, a neuronal basic helix-loop-helix transcription factor, is downregulated in glioblastoma patients and functions as a tumor suppressor under hypoxic microenvironment. Agrawal R; Garg A; Benny Malgulwar P; Sharma V; Sarkar C; Kulshreshtha R Int J Cancer; 2018 May; 142(9):1817-1828. PubMed ID: 29226333 [TBL] [Abstract][Full Text] [Related]
23. Livin contributes to tumor hypoxia-induced resistance to cytotoxic therapies in glioblastoma multiforme. Hsieh CH; Lin YJ; Wu CP; Lee HT; Shyu WC; Wang CC Clin Cancer Res; 2015 Jan; 21(2):460-70. PubMed ID: 25370472 [TBL] [Abstract][Full Text] [Related]
24. The N Zhao R; Li B; Zhang S; He Z; Pan Z; Guo Q; Qiu W; Qi Y; Zhao S; Wang S; Chen Z; Zhang P; Guo X; Xue H; Li G Front Immunol; 2021; 12():653711. PubMed ID: 34354698 [TBL] [Abstract][Full Text] [Related]
25. Hypoxia-inducible miR-196a modulates glioblastoma cell proliferation and migration through complex regulation of NRAS. Takkar S; Sharma V; Ghosh S; Suri A; Sarkar C; Kulshreshtha R Cell Oncol (Dordr); 2021 Apr; 44(2):433-451. PubMed ID: 33469841 [TBL] [Abstract][Full Text] [Related]
26. KDM5C is transcriptionally regulated by BRD4 and promotes castration-resistance prostate cancer cell proliferation by repressing PTEN. Hong Z; Wu G; Xiang ZD; Xu CD; Huang SS; Li C; Shi L; Wu DL Biomed Pharmacother; 2019 Jun; 114():108793. PubMed ID: 30921702 [TBL] [Abstract][Full Text] [Related]
27. Hypoxia and hypoxia-inducible factors in glioblastoma multiforme progression and therapeutic implications. Yang L; Lin C; Wang L; Guo H; Wang X Exp Cell Res; 2012 Nov; 318(19):2417-26. PubMed ID: 22906859 [TBL] [Abstract][Full Text] [Related]
28. Hypoxia-inducible lncRNA MIR210HG interacting with OCT1 is involved in glioblastoma multiforme malignancy. Ho KH; Shih CM; Liu AJ; Chen KC Cancer Sci; 2022 Feb; 113(2):540-552. PubMed ID: 34897892 [TBL] [Abstract][Full Text] [Related]
29. The role of factor inhibiting HIF (FIH-1) in inhibiting HIF-1 transcriptional activity in glioblastoma multiforme. Wang E; Zhang C; Polavaram N; Liu F; Wu G; Schroeder MA; Lau JS; Mukhopadhyay D; Jiang SW; O'Neill BP; Datta K; Li J PLoS One; 2014; 9(1):e86102. PubMed ID: 24465898 [TBL] [Abstract][Full Text] [Related]
30. Single-cell RNA sequencing identifies critical transcription factors of tumor cell invasion induced by hypoxia microenvironment in glioblastoma. Zhang Y; Zhang B; Lv C; Zhang N; Xing K; Wang Z; Lv R; Yu M; Xu C; Wang Y Theranostics; 2023; 13(11):3744-3760. PubMed ID: 37441593 [No Abstract] [Full Text] [Related]
31. Hypoxia-Induced Autophagy Is Involved in Radioresistance via HIF1A-Associated Beclin-1 in Glioblastoma Multiforme. Wei J; Zhu K; Yang Z; Zhou Y; Xia Z; Ren J; Zhao Y; Wu G; Liu C Heliyon; 2023 Jan; 9(1):e12820. PubMed ID: 36691538 [TBL] [Abstract][Full Text] [Related]
32. Antioxidant network-based signatures cluster glioblastoma into distinct redox-resistant phenotypes. Yang Y; More S; De Smet F; De Vleeschouwer S; Agostinis P Front Immunol; 2024; 15():1342977. PubMed ID: 38698847 [TBL] [Abstract][Full Text] [Related]
33. High expression of RFX4 is associated with tumor progression and poor prognosis in patients with glioblastoma. Jeong HY; Kim HJ; Kim CE; Lee S; Choi MC; Kim SH Int J Neurosci; 2021 Jan; 131(1):7-14. PubMed ID: 32075484 [No Abstract] [Full Text] [Related]
34. Insights into The Function and Regulation of Jumonji C Lysine Demethylases as Hypoxic Responsive Enzymes. Chopra A; Adhikary H; Willmore WG; Biggar KK Curr Protein Pept Sci; 2020; 21(7):642-654. PubMed ID: 31889485 [TBL] [Abstract][Full Text] [Related]
35. Expanding the genetics and phenotypic spectrum of Lysine-specific demethylase 5C (KDM5C): a report of 13 novel variants. Leonardi E; Aspromonte MC; Drongitis D; Bettella E; Verrillo L; Polli R; McEntagart M; Licchetta L; Dilena R; D'Arrigo S; Ciaccio C; Esposito S; Leuzzi V; Torella A; Baldo D; Lonardo F; Bonato G; Pellegrin S; Stanzial F; Posmyk R; Kaczorowska E; Carecchio M; Gos M; Rzońca-Niewczas S; Miano MG; Murgia A Eur J Hum Genet; 2023 Feb; 31(2):202-215. PubMed ID: 36434256 [TBL] [Abstract][Full Text] [Related]
36. Lysine demethylase 5C inhibits transcription of prefoldin subunit 5 to activate c-Myc signal transduction and colorectal cancer progression. Yu F; Li L; Gu Y; Wang S; Zhou L; Cheng X; Jiang H; Huang Y; Zhang Y; Qian W; Li X; Liu Z Mol Med; 2024 Jan; 30(1):9. PubMed ID: 38216914 [TBL] [Abstract][Full Text] [Related]
37. Human umbilical cord mesenchymal stem cells-derived exosomal microRNA-181a retards nasopharyngeal carcinoma development by mediating KDM5C. Liu J; Zhu M; Tang Q J Cancer Res Clin Oncol; 2021 Oct; 147(10):2867-2877. PubMed ID: 34218325 [TBL] [Abstract][Full Text] [Related]
38. miR128-1 inhibits the growth of glioblastoma multiforme and glioma stem-like cells via targeting BMI1 and E2F3. Shan ZN; Tian R; Zhang M; Gui ZH; Wu J; Ding M; Zhou XF; He J Oncotarget; 2016 Nov; 7(48):78813-78826. PubMed ID: 27705931 [TBL] [Abstract][Full Text] [Related]
39. Hypoxia-mediated cancer stem cells in pseudopalisades with activation of hypoxia-inducible factor-1α/Akt axis in glioblastoma. Inukai M; Hara A; Yasui Y; Kumabe T; Matsumoto T; Saegusa M Hum Pathol; 2015 Oct; 46(10):1496-505. PubMed ID: 26256949 [TBL] [Abstract][Full Text] [Related]
40. ALKBH5 Facilitates Hypoxia-Induced Paraspeckle Assembly and IL8 Secretion to Generate an Immunosuppressive Tumor Microenvironment. Dong F; Qin X; Wang B; Li Q; Hu J; Cheng X; Guo D; Cheng F; Fang C; Tan Y; Yan H; He Y; Sun X; Yuan Y; Liu H; Li T; Zhao Y; Kang C; Wu X Cancer Res; 2021 Dec; 81(23):5876-5888. PubMed ID: 34670781 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]